- HOME
- 연구현황
- 연구활동
연구활동
| 소속 | 주요저자 | 학술지명 | 논문제목 | IF |
|---|---|---|---|---|
| 핵의학과 | *유장, 천미주 | Cancers | Radiomics Analysis of 18F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery, 2023 Mar 28;15(7):2012. | 6.575 |
| 감염내과 | 함신영, 이승재 | J Korean Med Sci | Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding, 2023 Feb 27;38(8):e59. | 5.354 |
| 외과 | *윤호근 | Clinical Nutrition ESPEN | Trends in vitamin D level and risk of vitamin D deficiency after gastrectomy for gastric cancer: A retrospective study of a single high-volume center experience, 2023 Feb;53:74-79. | 2.38 |
| 정형외과 | *이승훈 | Clinical Psychopharmacology and Neuroscience | Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression, 2023 Feb 28;21(1):147-161. | 3.731 |
| 신경외과 | *홍창의 | Journal of Neuroradiology | Gamma knife radiosurgery-induced intracranial aneurysms: A case series and literature review, 2023 Feb;50(1):36-39. | 4.6 |
| 혈액종양내과, 보훈의학연구소 | *윤재원, **임태규, 권정 | Medicina | Long-Term Response of Pembrolizumab in a Patient with Metastatic Squamous Non-Small Cell Lung Cancer on Hemodialysis: Case Report and Review of the Literature, 2023 Feb 9;59(2):325. | 2.948 |
| 병리과, 핵의학과, 보훈의학연구소 | *김지환, **김준엽, 천미주, 전종후, 이영, 김승민 | Clinical Nuclear Medicine | Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease, 2023 Feb 1;48(2):143-149. | 10.782 |
| 호흡기 알레르기 내과 | *원하경 | Allergy Asthma Immunol Res. | Staphylococcal Enterotoxin-Specific IgE Sensitization: A Potential Predictor of Fixed Airflow Obstruction in Elderly Asthma, 2023 Mar;15(2):160-173. | 5.096 |
| 신장내과 | 이동영 | Journal of Personalized Medicine | Plasma Interleukin-6 Level Predicts the Risk of Arteriovenous Fistula Dysfunction in Patients Undergoing Maintenance Hemodialysis, 2023 Jan 12;13(1):151. | 3.508 |
| 감염내과 | 김춘관 | Antimicrob Agents Chemother | A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-1, 2023 Jan 24;67(1):e0045222. | 5.938 |
* 제1저자, ** 교신저자
